drugset / Trial / NCT05127369

Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression

NCT05127369

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a single center phase I / II clinical trial. Randomized, blind and positive drug parallel control were used to evaluate the safety and effectiveness of dental pulp mesenchymal cell injection in the treatment of depression 8 weeks after administration

Timeline

Start
2022-01-01
Primary completion
2023-12-30
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dental pulp mesenchymal cell injection Unknown 0.1 iu/kg Intravenous
Subject Fluoxetine Small molecule 40 mg Oral

Indications